Cancer.Net   
 Journal of Clinical Oncology   
 Journal of Oncology Practice   
 ASCO News & Forum   
 The ASCO Cancer Foundation   
 ASCO Press Center   
 

Home > Legislative & Regulatory > Legislative and Regulatory Issues > Policy Issues > Drug Safety > Legislation & Congressional Advocacy


Legislation & Congressional Advocacy


This section includes relevant legislation from both the United States Senate and House of Representatives and any background materials that may accompany the legislation.  You can also find letters to and from Members of Congress regarding drug safety.

Legislation
Senate HELP Committee Summary of S. 3807
S. 3807, Enhancing Drug Safety and Innovation Act of 2006
S. 1956, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act
H.R. 2090, Food and Drug Administration Improvement Act of 2005
S. 930, Food and Drug Administration Safety Act of 2005
H.R. 4429, Food and Drug Administration Safety Act of 2005

Congressional Letters
Enzi-Kennedy Letter to the FDA